IDEAS home Printed from https://ideas.repec.org/a/eee/hepoli/v91y2009i2p135-141.html
   My bibliography  Save this article

Does social marketing provide a framework for changing healthcare practice?

Author

Listed:
  • Morris, Zoë Slote
  • Clarkson, Peter John

Abstract

Objectives We argue that social marketing can be used as a generic framework for analysing barriers to the take-up of clinical guidelines, and planning interventions which seek to enable this change.Methods We reviewed the literature on take-up of clinical guidelines, in particular barriers and enablers to change; social marketing principles and social marketing applied to healthcare. We then applied the social marketing framework to analyse the literature and to consider implications for future guideline policy to assess its feasibility and accessibility.Results There is sizeable extant literature on healthcare practitioners' non-compliance with clinical guidelines. This is an international problem common to a number of settings. The reasons for poor levels of take up appear to be well understood, but not addressed adequately in practice. Applying a social marketing framework brings new insights to the problem."Conclusions We show that a social marketing framework provides a useful solution-focused framework for systematically understanding barriers to individual behaviour change and designing interventions accordingly. Whether the social marketing framework provides an effective means of bringing about behaviour change remains an empirical question which has still to be tested in practice. The analysis presented here provides strong motivation to begin such testing.

Suggested Citation

  • Morris, Zoë Slote & Clarkson, Peter John, 2009. "Does social marketing provide a framework for changing healthcare practice?," Health Policy, Elsevier, vol. 91(2), pages 135-141, July.
  • Handle: RePEc:eee:hepoli:v:91:y:2009:i:2:p:135-141
    as

    Download full text from publisher

    File URL: http://www.sciencedirect.com/science/article/pii/S0168-8510(08)00258-3
    Download Restriction: Full text for ScienceDirect subscribers only
    ---><---

    As the access to this document is restricted, you may want to search for a different version of it.

    References listed on IDEAS

    as
    1. Rashidian, Arash & Eccles, Martin P. & Russell, Ian, 2008. "Falling on stony ground A qualitative study of implementation of clinical guidelines' prescribing recommendations in primary care," Health Policy, Elsevier, vol. 85(2), pages 148-161, February.
    2. Leys, Mark, 2003. "Health care policy: qualitative evidence and health technology assessment," Health Policy, Elsevier, vol. 65(3), pages 217-226, September.
    3. Ouimet, Mathieu & Landry, Réjean & Amara, Nabil & Belkhodja, Omar, 2006. "What factors induce health care decision-makers to use clinical guidelines? Evidence from provincial health ministries, regional health authorities and hospitals in Canada," Social Science & Medicine, Elsevier, vol. 62(4), pages 964-976, February.
    4. Cairns, John, 2006. "Providing guidance to the NHS: The Scottish Medicines Consortium and the National Institute for Clinical Excellence compared," Health Policy, Elsevier, vol. 76(2), pages 134-143, April.
    5. Casparie, Anton F. & M. Sluijs, Emmy & Wagner, Cordula & de Bakker, Dinny H., 1997. "Quality systems in Dutch health care institutions," Health Policy, Elsevier, vol. 42(3), pages 255-267, December.
    6. McMahon, Meghan & Morgan, Steve & Mitton, Craig, 2006. "The Common Drug Review: A NICE start for Canada?," Health Policy, Elsevier, vol. 77(3), pages 339-351, August.
    7. Lawton, Rebecca & Parker, Dianne, 1999. "Procedures and the professional: the case of the British NHS," Social Science & Medicine, Elsevier, vol. 48(3), pages 353-361, February.
    Full references (including those not matched with items on IDEAS)

    Citations

    Citations are extracted by the CitEc Project, subscribe to its RSS feed for this item.
    as


    Cited by:

    1. Beatriz Casais & João F. Proença, 2010. "Inhibitions and implications associated with celebrity participation in social marketing programs focusing on HIV prevention: an exploratory research," FEP Working Papers 360, Universidade do Porto, Faculdade de Economia do Porto.
    2. Chi-Horng Liao, 2020. "Evaluating the Social Marketing Success Criteria in Health Promotion: A F-DEMATEL Approach," IJERPH, MDPI, vol. 17(17), pages 1-19, August.
    3. Adela Laura Popa & Naiana Nicoleta Ţarcă & Dinu Vlad Sasu & Simona Aurelia Bodog & Remus Dorel Roşca & Teodora Mihaela Tarcza, 2022. "Exploring Marketing Insights for Healthcare: Trends and Perspectives Based on Literature Investigation," Sustainability, MDPI, vol. 14(17), pages 1-21, August.
    4. Paramonovs Sergejs & Ijevleva Ksenija, 2015. "The Role of Marketing Tools in the Improvement of Consumers Financial Literacy," Economics and Business, Sciendo, vol. 27(1), pages 40-45, August.

    Most related items

    These are the items that most often cite the same works as this one and are cited by the same works as this one.
    1. Nicod, Elena & Kanavos, Panos, 2012. "Commonalities and differences in HTA outcomes: A comparative analysis of five countries and implications for coverage decisions," Health Policy, Elsevier, vol. 108(2), pages 167-177.
    2. Phulkerd, Sirinya & Sacks, Gary & Vandevijvere, Stefanie & Worsley, Anthony & Lawrence, Mark, 2017. "Barriers and potential facilitators to the implementation of government policies on front-of-pack food labeling and restriction of unhealthy food advertising in Thailand," Food Policy, Elsevier, vol. 71(C), pages 101-110.
    3. Spyridonidis, Dimitrios & Calnan, Michael, 2011. "Opening the black box: A study of the process of NICE guidelines implementation," Health Policy, Elsevier, vol. 102(2), pages 117-125.
    4. Estabrooks, Carole A. & Norton, Peter & Birdsell, Judy M. & Newton, Mandi S. & Adewale, Adeniyi J. & Thornley, Richard, 2008. "Knowledge translation and research careers: Mode I and Mode II activity among health researchers," Research Policy, Elsevier, vol. 37(6-7), pages 1066-1078, July.
    5. Michael Drummond & Bengt Jönsson & Frans Rutten & Tom Stargardt, 2011. "Reimbursement of pharmaceuticals: reference pricing versus health technology assessment," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 12(3), pages 263-271, June.
    6. Alison Bullock & Zoё Slote Morris & Christine Atwell, 2013. "Exchanging knowledge through healthcare manager placements in research teams," The Service Industries Journal, Taylor & Francis Journals, vol. 33(13-14), pages 1363-1380, October.
    7. Solomon, Josie & Knapp, Peter & Raynor, D.K. & Atkin, Karl, 2013. "Worlds apart? An exploration of prescribing and medicine-taking decisions by patients, GPs and local policy makers," Health Policy, Elsevier, vol. 112(3), pages 264-272.
    8. Jennifer Whitty & Paul Scuffham & Sharyn Rundle-Thielee, 2011. "Public and decision maker stated preferences for pharmaceutical subsidy decisions," Applied Health Economics and Health Policy, Springer, vol. 9(2), pages 73-79, March.
    9. Lombarts, M. J. M. H. & Klazinga, N. S., 2001. "A policy analysis of the introduction and dissemination of external peer review (visitatie) as a means of professional self-regulation amongst medical specialists in The Netherlands in the period 1985," Health Policy, Elsevier, vol. 58(3), pages 191-213, December.
    10. Mathieu Ouimet & Nabil Amara & Réjean Landry & John Lavis, 2007. "Direct interactions medical school faculty members have with professionals and managers working in public and private sector organizations: A cross-sectional study," Scientometrics, Springer;Akadémiai Kiadó, vol. 72(2), pages 307-323, August.
    11. Armstrong, Kristy & Mitton, Craig & Carleton, Bruce & Shoveller, Jean, 2008. "Drug formulary decision-making in two regional health authorities in British Columbia, Canada," Health Policy, Elsevier, vol. 88(2-3), pages 308-316, December.
    12. Federico Pennestrì & Giuseppe Banfi, 2022. "The Experience of Patients in Chronic Care Management: Applications in Health Technology Assessment (HTA) and Value for Public Health," IJERPH, MDPI, vol. 19(16), pages 1-8, August.
    13. Pääkkönen, Jenni & Seppälä, Timo, 2012. "Dimensions of health care system quality in Finland," Working Papers 31, VATT Institute for Economic Research.
    14. Fischer, Katharina E. & Rogowski, Wolf H. & Leidl, Reiner & Stollenwerk, Björn, 2013. "Transparency vs. closed-door policy: Do process characteristics have an impact on the outcomes of coverage decisions? A statistical analysis," Health Policy, Elsevier, vol. 112(3), pages 187-196.
    15. Csanádi, Marcell & Ozierański, Piotr & Löblová, Olga & King, Lawrence & Kaló, Zoltán & Botz, Lajos, 2019. "Shedding light on the HTA consultancy market: Insights from Poland," Health Policy, Elsevier, vol. 123(12), pages 1237-1243.
    16. Manish Barman & Narendra Kumar & Barman Palak, 2019. "Health Technology Assessments - Evidence Based Approach for A Sustainable Future of Healthcare," Biomedical Journal of Scientific & Technical Research, Biomedical Research Network+, LLC, vol. 20(3), pages 14966-14969, August.
    17. Rosenberg-Yunger, Zahava R.S. & Bayoumi, Ahmed M., 2014. "Transparency in Canadian public drug advisory committees," Health Policy, Elsevier, vol. 118(2), pages 255-263.
    18. Eun-Young Bae & Hui Jeong Kim & Hye-Jae Lee & Junho Jang & Seung Min Lee & Yunkyung Jung & Nari Yoon & Tae Kyung Kim & Kookhee Kim & Bong-Min Yang, 2018. "Role of economic evidence in coverage decision-making in South Korea," PLOS ONE, Public Library of Science, vol. 13(10), pages 1-12, October.
    19. Milewa, Timothy, 2006. "Health technology adoption and the politics of governance in the UK," Social Science & Medicine, Elsevier, vol. 63(12), pages 3102-3112, December.
    20. Anderson, Michael & Drummond, Michael & Taylor, David & McGuire, Alistair & Carter, Paul & Mossialos, Elias, 2022. "Promoting innovation while controlling cost: The UK's approach to health technology assessment," Health Policy, Elsevier, vol. 126(3), pages 224-233.

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:eee:hepoli:v:91:y:2009:i:2:p:135-141. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Catherine Liu or the person in charge (email available below). General contact details of provider: http://www.elsevier.com/locate/healthpol .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.